J&J inks last-minute Risperdal deal in boy-with-breasts case

$2.2 Billion Risperdal Settlement

Johnson & Johnson has agreed to pay more than $2.2 billion in criminal and civil fines to settle accusations that it improperly promoted the antipsychotic drug Risperdal to older adults, children and people with developmental disabilities, the Justice …

More here

Johnson & Johnson Settles 3rd Risperdal Lawsuit for $158M

They just got dinged with a $158 million settlement in a Medicaid fraud case in Texas for “making false or misleading statements about the safety, cost and effectiveness of the expensive anti-psychotic medication Risperdal, and improperly influencing

Leave a Comment

Your email address will not be published. Required fields are marked *